Cell Culture Market by Consumables [Media, Sera, Reagents (Supplements, Buffers)], Vessels (Plates, Flask, Roller Bottle), Equipment (Bioreactor, Filtration, Incubators, Centrifuge), Application (mAbs, Vaccines, CGT), Competition - Global Forecast to 2031

1 INTRODUCTION 60 1.1 STUDY OBJECTIVES 60 1.2 MARKET DEFINITION 60 1.2.1 INCLUSIONS & EXCLUSIONS 61 1.3 STUDY SCOPE 61 1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 62 1.3.2 YEARS CONSIDERED 63 1.3.3 CURRENCY CONSIDERED 64 1.3.4 UNIT CONSIDERED 64 1.4 STAKEHOLDERS 64 1.5 SUMMARY OF CHANGES 64 2 EXECUTIVE SUMMARY 66 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 66 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 68 2.3 DISRUPTIVE TRENDS IN CELL CULTURE MARKET 69 2.4 HIGH-GROWTH SEGMENTS 70 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 71 3 PREMIUM INSIGHTS 72 3.1 CELL CULTURE MARKET OVERVIEW 72 3.2 NORTH AMERICA: CELL CULTURE MARKET, BY CONSUMABLE AND COUNTRY 73 3.3 CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 74 3.4 CELL CULTURE MARKET SHARE, BY END USER 74 4 MARKET OVERVIEW 75 4.1 INTRODUCTION 75 4.2 MARKET DYNAMICS 75 4.2.1 DRIVERS 76 4.2.1.1 Increasing support and funding for cell-based research 76 4.2.1.2 Rising demand for serum-free and animal component-free media 78 4.2.1.3 Growing popularity of monoclonal antibodies and biosimilars 79 4.2.1.4 Increasing adoption of single-use technologies 82 4.2.1.5 Growth in advanced therapy medicinal products 82 4.2.2 RESTRAINTS 84 4.2.2.1 High cost of cell biology research 84 4.2.2.2 Limitations in producing high-density cell cultures 84   4.2.3 OPPORTUNITIES 85 4.2.3.1 Rising demand for 3D cell culture 85 4.2.3.2 Growth opportunities in emerging economies 86 4.2.3.3 Increasing focus on next-generation therapeutics 87 4.2.4 CHALLENGES 88 4.2.4.1 Disposal of plastic consumables 88 4.2.4.2 Ethical concerns related to cell usage 89 4.3 UNMET NEEDS & WHITE SPACES 90 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 90 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 91 5 INDUSTRY TRENDS 92 5.1 PORTER’S FIVE FORCES ANALYSIS 92 5.1.1 BARGAINING POWER OF SUPPLIERS 93 5.1.2 BARGAINING POWER OF BUYERS 93 5.1.3 THREAT OF NEW ENTRANTS 93 5.1.4 THREAT OF SUBSTITUTES 93 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 93 5.2 MACROECONOMIC OUTLOOK 93 5.2.1 INTRODUCTION 93 5.2.2 GDP TRENDS & FORECAST 94 5.2.3 TRENDS IN GLOBAL CELL CULTURE INDUSTRY 94 5.3 VALUE CHAIN ANALYSIS 95 5.4 ECOSYSTEM ANALYSIS 96 5.5 PRICING ANALYSIS 99 5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 99 5.5.2 AVERAGE SELLING PRICE TREND OF CELL CULTURE PRODUCTS, BY REGION 101 5.6 TRADE ANALYSIS 102 5.6.1 IMPORT SCENARIO (HS CODE 382100) 103 5.6.2 EXPORT SCENARIO (HS CODE 382100) 104 5.7 KEY CONFERENCES AND EVENTS, 2026–2027 105 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 106 5.9 INVESTMENT AND FUNDING SCENARIO 107 5.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE 108 5.10 IMPACT OF 2025 US TARIFFS ON CELL CULTURE MARKET 109 5.10.1 INTRODUCTION 109 5.10.2 KEY TARIFF RATES 109 5.10.3 PRICE IMPACT ANALYSIS 110 5.10.4 IMPACT ON COUNTRY/REGION 111 5.10.4.1 US 111 5.10.4.2 Europe 111 5.10.4.3 Asia Pacific 112 5.10.5 IMPACT ON END-USE INDUSTRIES 112 5.10.5.1 Pharmaceutical & biotech companies 112 5.10.5.2 Hospitals & diagnostic laboratories 113 5.10.5.3 Academic & research institutes 113 5.10.5.4 Contract research organizations & contract development and manufacturing organizations 113 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS 114 6.1 TECHNOLOGY ANALYSIS 114 6.1.1 KEY EMERGING TECHNOLOGIES 114 6.1.1.1 Single-use technology 114 6.1.1.2 Flow cytometry 116 6.1.1.3 Microscopy 116 6.1.2 COMPLEMENTARY TECHNOLOGIES 116 6.1.2.1 High-throughput screening 116 6.1.2.2 Mass spectrometry 116 6.1.3 ADJACENT TECHNOLOGIES 117 6.1.3.1 Microfluidics and organ-on-a-chip 117 6.1.3.2 3D bioprinting 117 6.2 TECHNOLOGY/PRODUCT ROADMAP 118 6.3 PATENT ANALYSIS 118 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR CELL CULTURE PATENTS 119 6.4 FUTURE APPLICATIONS 121 6.5 IMPACT OF AI/GEN AI ON CELL CULTURE MARKET 122 6.5.1 BEST PRACTICES IN CELL CULTURE WORKFLOW 123 6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN CELL CULTURE MARKET 124 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 124 6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN CELL CULTURE MARKET 124 7 SUSTAINABILITY & REGULATORY LANDSCAPE 126 7.1 REGIONAL REGULATIONS & COMPLIANCE 126 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 126 7.1.2 REGULATORY FRAMEWORK 129 7.1.2.1 North America 129 7.1.2.2 Europe 129 7.1.2.3 Asia Pacific 130 7.1.2.4 Latin America 131 7.1.2.5 Middle East & Africa 131 7.1.3 INDUSTRY STANDARDS 131   7.2 SUSTAINABILITY INITIATIVES 132 7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 132 7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 133 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 134 8.1 DECISION-MAKING PROCESS 134 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 134 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 134 8.2.2 KEY BUYING CRITERIA, BY END USER 135 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 137 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 137 8.5 MARKET PROFITABILITY 137 9 CELL CULTURE MARKET, BY PRODUCT 138 9.1 INTRODUCTION 139 9.2 CONSUMABLES 139 9.2.1 SERA, MEDIA, AND REAGENTS 143 9.2.1.1 Media 147 9.2.1.1.1 Serum-free media 151 9.2.1.1.1.1 CHO media 156 9.2.1.1.1.1.1 High-yield biologics manufacturing to sustain demand for optimized CHO serum-free media 156 9.2.1.1.1.2 HEK 293 media 159 9.2.1.1.1.2.1 Viral vector manufacturing and transient expression workflows to accelerate HEK 293 media adoption 159 9.2.1.1.1.3 Serum-free stem cell media 163 9.2.1.1.1.3.1 Regenerative medicine, iPSC models, and cell therapy translation to drive specialized stem cell media demand 163 9.2.1.1.1.4 Vero Cell media 166 9.2.1.1.1.4.1 Increasing vaccine manufacturing to support demand for serum-free Vero cell media 166 9.2.1.1.1.5 BHK media 170 9.2.1.1.1.5.1 Vaccine production and viral vector workflows to support demand for BHK serum-free media 170 9.2.1.1.1.6 Other serum-free media 173 9.2.1.1.2 Classical media & salts 176 9.2.1.1.2.1 Standardized basal media and salt solutions to support routine culture, assay reproducibility, and vaccine production 176 9.2.1.1.3 Stem cell culture media 180 9.2.1.1.3.1 Rising use of stem cell models and regenerative medicine workflows to drive demand for specialized culture media 180   9.2.1.1.4 Chemically-defined media 183 9.2.1.1.4.1 Increasing need for reproducible, animal component-free workflows to support biologics and advanced therapy development 183 9.2.1.1.5 Specialty media 187 9.2.1.1.5.1 Suitability for use in selective cell types in bioprocessing and biomanufacturing industries to boost market 187 9.2.1.1.6 Other media 191 9.2.1.2 Reagents 195 9.2.1.2.1 Growth factors 199 9.2.1.2.1.1 Need to regulate cell proliferation, differentiation, and migration to sustain growth 199 9.2.1.2.2 Supplements 202 9.2.1.2.2.1 Need to improve cell growth, nutrient availability, and bioproduction performance to support segment growth 202 9.2.1.2.3 Buffers & chemicals 206 9.2.1.2.3.1 Ability to maintain stable pH levels to facilitate growth 206 9.2.1.2.4 Cell dissociation reagents 209 9.2.1.2.4.1 Ability to minimize cell stress and reduce cell damage to foster growth 209 9.2.1.2.5 Balanced salt solutions 213 9.2.1.2.5.1 Ability to maintain optimal physiological conditions for cell growth and experimentation to assist growth 213 9.2.1.2.6 Attachment & matrix factors 216 9.2.1.2.6.1 Rising adoption of 3D cell culture models to support growth 216 9.2.1.2.7 Antibiotics/Antimycotics 220 9.2.1.2.7.1 Ability to mitigate growth of contaminating bacteria, fungi, and mycoplasma to drive market 220 9.2.1.2.8 Cryoprotective reagents 223 9.2.1.2.8.1 Ability to preserve cell viability during freezing and thawing to aid growth 223 9.2.1.2.9 Contamination detection kits 226 9.2.1.2.9.1 Need for rapid identification of microbial contaminants to promote growth 226 9.2.1.2.10 Other reagents 230 9.2.1.3 Sera 233 9.2.1.3.1 Fetal bovine sera 236 9.2.1.3.1.1 Increasing role of fetal bovine sera in cell proliferation to favor growth 236 9.2.1.3.2 Adult bovine sera 240 9.2.1.3.2.1 Cost-effectiveness to contribute to growth 240 9.2.1.3.3 Other animal sera 243   9.2.2 VESSELS 247 9.2.2.1 Cell factory systems/cell stacks 250 9.2.2.1.1 Efficient and scalable solutions for large-scale expansion to drive adoption 250 9.2.2.2 Roller/roux bottles 254 9.2.2.2.1 Scalability, cost-effectiveness, and ease of handling to support growth 254 9.2.2.3 Flasks 257 9.2.2.3.1 Growing advancements in cell culture flasks to boost market 257 9.2.2.4 Multiwell plates 261 9.2.2.4.1 Increasing adoption of multiwell plates in high-throughput or high-content screening to aid growth 261 9.2.2.5 Petri dishes 264 9.2.2.5.1 Rising use of petri dishes as sterile containers to sustain growth 264 9.2.3 OTHER CONSUMABLES & ACCESSORIES 267 9.2.3.1 Reduced preparation time and equipment performance improvements to augment growth 267 9.3 EQUIPMENT 270 9.3.1 SUPPORTING EQUIPMENT 274 9.3.1.1 Filtration systems 277 9.3.1.1.1 Sterile filtration for contamination-controlled workflows to boost market 277 9.3.1.2 Cell counters 281 9.3.1.2.1 Growing adoption of automated cell counters to propel market 281 9.3.1.3 Carbon dioxide incubators 285 9.3.1.3.1 Increasing focus of research institutes on developing lab-scale incubators to drive market 285 9.3.1.4 Centrifuges 289 9.3.1.4.1 Increasing demand for bioproduction applications to drive adoption of centrifuges 289 9.3.1.5 Autoclaves 293 9.3.1.5.1 Reliance on single-use labware and equipment to affect demand for autoclaves 293 9.3.1.6 Microscopes 296 9.3.1.6.1 Rising adoption of live-cell imaging in 3D culture and stem cell models to support segment growth 296 9.3.1.7 Biosafety cabinets 300 9.3.1.7.1 Rising focus on contamination control and operator safety to support segment growth 300 9.3.1.8 Other supporting equipment 304   9.3.2 BIOREACTORS 307 9.3.2.1 Rising biologics and advanced therapy production to accelerate adoption of scalable bioreactor systems 307 9.3.3 STORAGE EQUIPMENT 311 9.3.3.1 Refrigerators & freezers 315 9.3.3.1.1 Increasing need for storage solutions to propel market 315 9.3.3.2 Cryostorage systems 318 9.3.3.2.1 Benefits of long-term preservation of cell cultures to support growth 318 10 CELL CULTURE MARKET, BY APPLICATION 322 10.1 INTRODUCTION 323 10.2 BIOPHARMACEUTICAL PRODUCTION 323 10.2.1 MONOCLONAL ANTIBODY PRODUCTION 327 10.2.1.1 Increasing approval and launch of monoclonal antibodies to amplify growth 327 10.2.2 VACCINE PRODUCTION 331 10.2.2.1 Rising incidence of infectious diseases to support growth 331 10.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION 335 10.3 DIAGNOSTICS 338 10.3.1 USE OF CULTURED CELLS IN CYTOGENETICS AND ASSAY VALIDATION TO SUPPORT SEGMENT GROWTH 338 10.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE 342 10.4.1 CELL & GENE THERAPY 346 10.4.1.1 Rising approvals and manufacturing investments in advanced therapies to propel segment growth 346 10.4.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS 350 10.5 DRUG SCREENING & DEVELOPMENT 353 10.5.1 ADOPTION OF HUMAN-RELEVANT 3D MODELS AND AUTOMATED SCREENING PLATFORMS TO PROPEL SEGMENT GROWTH 353 10.6 OTHER APPLICATIONS 357 11 CELL CULTURE MARKET, BY END USER 360 11.1 INTRODUCTION 361 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 361 11.2.1 INCREASING DEMAND FOR CULTURE CELL LINES FOR DRUG SCREENING AND R&D TO AID GROWTH 361 11.3 HOSPITALS & DIAGNOSTIC LABORATORIES 365 11.3.1 GROWING USE OF CELL CULTURE FOR CELLULAR PHYSIOLOGY, DISEASE MECHANISMS, AND DRUG RESPONSES TO BOOST MARKET 365 11.4 ACADEMIC & RESEARCH INSTITUTES 369 11.4.1 RISING FUNDING ACTIVITIES TO CONTRIBUTE TO GROWTH 369 11.5 OTHER END USERS 372   12 CELL CULTURE MARKET, BY REGION 376 12.1 INTRODUCTION 377 12.2 NORTH AMERICA 377 12.2.1 US 385 12.2.1.1 Strong biologics pipeline and domestic cell therapy manufacturing investments to bolster growth 385 12.2.2 CANADA 392 12.2.2.1 Increasing funding and investments for cell-based therapies to boost market 392 12.3 EUROPE 399 12.3.1 GERMANY 406 12.3.1.1 Biologics manufacturing strength and mRNA oncology investments to drive demand 406 12.3.2 UK 412 12.3.2.1 ATMP clinical infrastructure and government life sciences strategy to boost growth 412 12.3.3 FRANCE 418 12.3.3.1 Rising number of cell-based research projects to enhance growth 418 12.3.4 ITALY 424 12.3.4.1 Strong government support for R&D activities to spur growth 424 12.3.5 SPAIN 430 12.3.5.1 Rising biotechnology R&D investment to support cell-based research applications 430 12.3.6 REST OF EUROPE 436 12.4 ASIA PACIFIC 442 12.4.1 CHINA 450 12.4.1.1 Large-scale CRDMO activity and multinational cell therapy investments to accelerate growth 450 12.4.2 JAPAN 457 12.4.2.1 Rising government initiatives and increasing investments in biotech to intensify growth 457 12.4.3 INDIA 463 12.4.3.1 Favorable government support and expansion by key cell culture players to augment growth 463 12.4.4 SOUTH KOREA 469 12.4.4.1 Growing pharmaceutical sector to drive market 469 12.4.5 AUSTRALIA 475 12.4.5.1 Regenerative medicine funding and hospital-linked CAR-T manufacturing to support growth 475 12.4.6 REST OF ASIA PACIFIC 481   12.5 LATIN AMERICA 488 12.5.1 BRAZIL 495 12.5.1.1 Cell therapy partnerships and vaccine manufacturing capacity to strengthen regional leadership 495 12.5.2 MEXICO 501 12.5.2.1 Pharmaceutical manufacturing investments and clinical research capacity to support steady growth 501 12.5.3 REST OF LATIN AMERICA 507 12.6 MIDDLE EAST 514 12.6.1 GCC COUNTRIES 521 12.6.1.1 Saudi Arabia 527 12.6.1.1.1 Increasing focus on expansion to drive market 527 12.6.1.2 UAE 533 12.6.1.2.1 Increasing shift from importing to manufacturing pharmaceuticals to boost market 533 12.6.1.3 Rest of GCC Countries 539 12.6.2 REST OF MIDDLE EAST 545 12.7 AFRICA 551 12.7.1 RISING GRANTS AND FUNDING FOR CELL AND GENE THERAPY PRODUCTS TO FOSTER GROWTH 551 13 COMPETITIVE LANDSCAPE 558 13.1 OVERVIEW 558 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 558 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL CULTURE MARKET 558 13.3 REVENUE ANALYSIS, 2021–2025 560 13.4 MARKET SHARE ANALYSIS, 2025 561 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 563 13.5.1 STARS 564 13.5.2 EMERGING LEADERS 564 13.5.3 PERVASIVE PLAYERS 564 13.5.4 PARTICIPANTS 564 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 566 13.5.5.1 Company footprint 566 13.5.5.2 Regional footprint 566 13.5.5.3 Product footprint 567 13.5.5.4 Application footprint 568 13.5.5.5 End-user footprint 569 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 570 13.6.1 PROGRESSIVE COMPANIES 570 13.6.2 RESPONSIVE COMPANIES 570 13.6.3 DYNAMIC COMPANIES 570 13.6.4 STARTING BLOCKS 570 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 571 13.6.5.1 Detailed list of key startups/SMEs 571 13.6.5.2 Competitive benchmarking of key startups/SMEs 572 13.7 COMPANY VALUATION AND FINANCIAL METRICS 573 13.7.1 FINANCIAL METRICS 573 13.7.2 COMPANY VALUATION 573 13.8 BRAND/PRODUCT COMPARISON 574 13.9 COMPETITIVE SCENARIO 574 13.9.1 PRODUCT LAUNCHES 574 13.9.2 DEALS 575 13.9.3 EXPANSIONS 576 14 COMPANY PROFILES 578 14.1 INTRODUCTION 578 14.2 KEY PLAYERS 578 14.2.1 THERMO FISHER SCIENTIFIC INC. 578 14.2.1.1 Business overview 578 14.2.1.2 Products offered 579 14.2.1.3 Recent developments 592 14.2.1.3.1 Product launches 592 14.2.1.3.2 Deals 594 14.2.1.3.3 Expansions 595 14.2.1.4 MnM view 596 14.2.1.4.1 Right to win 596 14.2.1.4.2 Strategic choices 596 14.2.1.4.3 Weaknesses and competitive threats 596 14.2.2 DANAHER CORPORATION 597 14.2.2.1 Business overview 597 14.2.2.2 Products offered 598 14.2.2.3 Recent developments 608 14.2.2.3.1 Product launches 608 14.2.2.3.2 Deals 609 14.2.2.3.3 Expansions 610 14.2.2.3.4 Other developments 611 14.2.2.4 MnM view 611 14.2.2.4.1 Right to win 611 14.2.2.4.2 Strategic choices 612 14.2.2.4.3 Weaknesses and competitive threats 612   14.2.3 MERCK KGAA 613 14.2.3.1 Business overview 613 14.2.3.2 Products offered 614 14.2.3.3 Recent developments 621 14.2.3.3.1 Product launches 621 14.2.3.3.2 Deals 621 14.2.3.3.3 Expansions 622 14.2.3.4 MnM view 624 14.2.3.4.1 Right to win 624 14.2.3.4.2 Strategic choices 624 14.2.3.4.3 Weaknesses and competitive threats 624 14.2.4 SARTORIUS AG 625 14.2.4.1 Business overview 625 14.2.4.2 Products offered 626 14.2.4.3 Recent developments 634 14.2.4.3.1 Product launches 634 14.2.4.3.2 Deals 635 14.2.4.3.3 Expansions 637 14.2.4.4 MnM view 638 14.2.4.4.1 Right to win 638 14.2.4.4.2 Strategic choices 638 14.2.4.4.3 Weaknesses and competitive threats 639 14.2.5 CORNING INCORPORATED 640 14.2.5.1 Business overview 640 14.2.5.2 Products offered 641 14.2.5.3 Recent developments 650 14.2.5.3.1 Deals 650 14.2.6 FUJIFILM HOLDINGS CORPORATION 652 14.2.6.1 Business overview 652 14.2.6.2 Products offered 653 14.2.6.3 Recent developments 659 14.2.6.3.1 Product launches 659 14.2.6.3.2 Deals 660 14.2.6.3.3 Other developments 660 14.2.7 BD 661 14.2.7.1 Business overview 661 14.2.7.2 Product offered 662 14.2.7.3 Recent developments 664 14.2.7.3.1 Product Launches 664 14.2.7.3.2 Deals 664 14.2.7.3.3 Other developments 665   14.2.8 EPPENDORF SE 666 14.2.8.1 Business overview 666 14.2.8.2 Products offered 667 14.2.8.3 Recent developments 672 14.2.8.3.1 Product launches 672 14.2.8.3.2 Expansions 673 14.2.9 LONZA 674 14.2.9.1 Business overview 674 14.2.9.2 Products offered 675 14.2.9.3 Recent developments 678 14.2.9.3.1 Product launches 678 14.2.9.3.2 Deals 678 14.2.10 GETINGE 679 14.2.10.1 Business overview 679 14.2.10.2 Products offered 680 14.2.10.3 Recent developments 681 14.2.10.3.1 Product launches 681 14.2.10.3.2 Deals 682 14.2.11 AGILENT TECHNOLOGIES, INC. 683 14.2.11.1 Business overview 683 14.2.11.2 Products offered 684 14.2.11.3 Recent developments 686 14.2.11.3.1 Product launches 686 14.2.11.3.2 Deals 687 14.2.11.3.3 Expansions 687 14.2.12 HIMEDIA LABORATORIES 688 14.2.12.1 Business overview 688 14.2.12.2 Products offered 688 14.2.13 BIO-TECHNE 692 14.2.13.1 Business overview 692 14.2.13.2 Products offered 693 14.2.13.3 Recent developments 697 14.2.13.3.1 Product launches 697 14.2.13.3.2 Deals 697 14.2.13.3.3 Expansions 698 14.3 OTHER PLAYERS 699 14.3.1 MILTENYI BIOTEC 699 14.3.2 STEMCELL TECHNOLOGIES 701 14.3.3 SOLIDA BIOTECH GMBH 704 14.3.4 CAISSON LABS 705 14.3.5 PROMOCELL GMBH 706 14.3.6 INVIVOGEN 707 14.3.7 PAN-BIOTECH 708 14.3.8 CELLEXUS 709 14.3.9 MEISSNER FILTRATION PRODUCTS, INC. 710 14.3.10 ADOLF KÜHNER AG 712 14.3.11 ADVANCION CORPORATION 713 14.3.12 BIOSPHERIX LLC 714 15 RESEARCH METHODOLOGY 715 15.1 RESEARCH DATA 715 15.1.1 SECONDARY DATA 716 15.1.1.1 Key secondary sources 716 15.1.1.2 Key data from secondary research 716 15.1.2 PRIMARY DATA 717 15.1.2.1 Key primary participants 717 15.1.2.2 Breakdown of primary interviews 717 15.1.2.3 Key data from primary sources 717 15.2 MARKET SIZE ESTIMATION 718 15.2.1 GLOBAL CELL CULTURE MARKET ESTIMATION, 2025 718 15.2.1.1 Approach 1: Company revenue analysis-based estimation (bottom-up) 718 15.2.1.2 Approach 2: Primary research 720 15.2.1.2.1 Key industry insights 720 15.2.1.3 Approach 3: MnM repository analysis 720 15.2.2 SEGMENTAL MARKET SIZE ESTIMATION, 2025 721 15.3 MARKET GROWTH RATE PROJECTIONS 722 15.4 DATA TRIANGULATION 724 15.5 RESEARCH ASSUMPTIONS 725 15.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT 726 16 APPENDIX 727 16.1 DISCUSSION GUIDE 727 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 731 16.3 CUSTOMIZATION OPTIONS 733 16.4 RELATED REPORTS 733 16.5 AUTHOR DETAILS 735

TABLE 1 CELL CULTURE MARKET: INCLUSIONS AND EXCLUSIONS 61 TABLE 2 CELL CULTURE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 76 TABLE 3 NATIONAL INSTITUTES OF HEALTH FUNDING FOR STEM CELL-BASED RESEARCH, 2020–2024 (USD MILLION) 77 TABLE 4 FUNDING INVESTMENTS IN CELL & GENE THERAPY, 2023–2026 77 TABLE 5 COMMERCIALLY SPONSORED MONOCLONAL ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN 2025 79 TABLE 6 ASIA PACIFIC: PRIVATE ROUNDS IN BIOTECH COMPANIES FOCUSED ON HEALTHCARE, 2024–2026 86 TABLE 7 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS 89 TABLE 8 CELL CULTURE MARKET: IMPACT OF PORTER’S FIVE FORCES 92 TABLE 9 CELL CULTURE MARKET: ROLE IN ECOSYSTEM 98 TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2023–2025 (USD) 99 TABLE 11 AVERAGE SELLING PRICE TREND OF CELL CULTURE PRODUCTS, BY REGION, 2023–2025 (USD) 101 TABLE 12 IMPORT DATA FOR HS CODE 382100, 2021–2025 (USD THOUSAND) 103 TABLE 13 IMPORT DATA FOR HS CODE 382100, 2021–2025 (TONS) 103 TABLE 14 EXPORT DATA FOR HS CODE 382100, 2021–2025 (USD THOUSAND) 104 TABLE 15 EXPORT DATA FOR HS CODE 382100, 2021–2025 (TONS) 105 TABLE 16 CELL CULTURE MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 105 TABLE 17 US ADJUSTED RECIPROCAL TARIFF RATES 109 TABLE 18 IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS 112 TABLE 19 ADVANTAGES OF SINGLE-USE OVER STAINLESS-STEEL BIOREACTORS 115 TABLE 20 ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE 117 TABLE 21 CELL CULTURE MARKET: INDICATIVE LIST OF PATENTS, 2026 120 TABLE 22 CASE STUDIES OF AI IMPLEMENTATION IN CELL CULTURE MARKET 124 TABLE 23 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN CELL CULTURE 125 TABLE 24 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 126 TABLE 25 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 126 TABLE 26 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 128 TABLE 27 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 128 TABLE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 135 TABLE 29 KEY BUYING CRITERIA, BY END USER 136 TABLE 30 CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 139 TABLE 31 CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 139 TABLE 32 CELL CULTURE CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 33 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 34 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 35 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 36 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 37 MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 38 GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 39 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 143 TABLE 40 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 144 TABLE 41 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 42 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 43 ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 44 LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 45 MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 146 TABLE 46 GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 47 CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 147 TABLE 48 CELL CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION) 148 TABLE 49 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 50 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 51 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 52 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 53 MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY REGION, 2024–2031 (USD MILLION) 150 TABLE 54 GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 55 CELL CULTURE MEDIA MARKET, BY REGION, 2024–2031 (MILLION LITERS) 151 TABLE 56 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS 152 TABLE 57 CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 152 TABLE 58 CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 59 NORTH AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 60 EUROPE: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 61 ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 62 LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 63 MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION) 155 TABLE 64 GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 65 CELL CULTURE MARKET FOR CHO MEDIA, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 66 NORTH AMERICA: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 67 EUROPE: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 68 ASIA PACIFIC: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 69 LATIN AMERICA: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 70 MIDDLE EAST: CELL CULTURE MARKET FOR CHO MEDIA, BY REGION, 2024–2031 (USD MILLION) 158 TABLE 71 GCC COUNTRIES: CELL CULTURE MARKET FOR CHO MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 72 CELL CULTURE MARKET FOR HEK 293 MEDIA, BY REGION, 2024–2031 (USD MILLION) 160 TABLE 73 NORTH AMERICA: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 74 EUROPE: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 75 ASIA PACIFIC: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 76 LATIN AMERICA: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 77 MIDDLE EAST: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 78 GCC COUNTRIES: CELL CULTURE MARKET FOR HEK 293 MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 79 CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 80 NORTH AMERICA: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 81 EUROPE: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 82 ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 83 LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 84 MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY REGION, 2024–2031 (USD MILLION) 165 TABLE 85 GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE STEM CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 86 CELL CULTURE MARKET FOR VERO CELL MEDIA, BY REGION, 2024–2031 (USD MILLION) 167 TABLE 87 NORTH AMERICA: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 88 EUROPE: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 89 ASIA PACIFIC: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 90 LATIN AMERICA: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 91 MIDDLE EAST: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY REGION, 2024–2031 (USD MILLION) 169 TABLE 92 GCC COUNTRIES: CELL CULTURE MARKET FOR VERO CELL MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 93 CELL CULTURE MARKET FOR BHK MEDIA, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 94 NORTH AMERICA: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 95 EUROPE: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 96 ASIA PACIFIC: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 97 LATIN AMERICA: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 98 MIDDLE EAST: CELL CULTURE MARKET FOR BHK MEDIA, BY REGION, 2024–2031 (USD MILLION) 172 TABLE 99 GCC COUNTRIES: CELL CULTURE MARKET FOR BHK MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 100 CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION) 173 TABLE 101 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 102 EUROPE: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 103 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 104 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 105 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY REGION, 2024–2031 (USD MILLION) 175 TABLE 106 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER SERUM-FREE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 107 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS 176 TABLE 108 CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 109 NORTH AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 110 EUROPE: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 111 ASIA PACIFIC: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 112 LATIN AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 113 MIDDLE EAST: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION, 2024–2031 (USD MILLION) 179 TABLE 114 GCC COUNTRIES: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 115 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS 180 TABLE 116 CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY REGION, 2024–2031 (USD MILLION) 180 TABLE 117 NORTH AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 118 EUROPE: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 119 ASIA PACIFIC: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 120 LATIN AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 121 MIDDLE EAST: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY REGION, 2024–2031 (USD MILLION) 182 TABLE 122 GCC COUNTRIES: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 123 CHEMICALLY-DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS 184 TABLE 124 CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION, 2024–2031 (USD MILLION) 184 TABLE 125 NORTH AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 126 EUROPE: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 127 ASIA PACIFIC: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 128 LATIN AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 129 MIDDLE EAST: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION, 2024–2031 (USD MILLION) 186 TABLE 130 GCC COUNTRIES: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 131 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS 187 TABLE 132 CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION, 2024–2031 (USD MILLION) 188 TABLE 133 NORTH AMERICA: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 134 EUROPE: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 135 ASIA PACIFIC: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 136 LATIN AMERICA: CELL CULTURE MARKET FOR SPECIALTY ME DIA, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 137 MIDDLE EAST: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION, 2024–2031 (USD MILLION) 190 TABLE 138 GCC COUNTRIES: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 139 OTHER MEDIA OFFERED BY KEY MARKET PLAYERS 191 TABLE 140 CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION, 2024–2031 (USD MILLION) 192 TABLE 141 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 142 EUROPE: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 143 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 144 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 145 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION, 2024–2031 (USD MILLION) 194 TABLE 146 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 147 CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 148 CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 196 TABLE 149 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 150 EUROPE: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 151 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 152 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 153 MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 154 GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 155 CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2024–2031 (USD MILLION) 199 TABLE 156 NORTH AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 157 EUROPE: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 158 ASIA PACIFIC: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 159 LATIN AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 160 MIDDLE EAST: CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 161 GCC COUNTRIES: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 162 CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION, 2024–2031 (USD MILLION) 203 TABLE 163 NORTH AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 164 EUROPE: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 165 ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 166 LATIN AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 167 MIDDLE EAST: CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION, 2024–2031 (USD MILLION) 205 TABLE 168 GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 169 CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION, 2024–2031 (USD MILLION) 206 TABLE 170 NORTH AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 171 EUROPE: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 172 ASIA PACIFIC: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 173 LATIN AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 174 MIDDLE EAST: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION, 2024–2031 (USD MILLION) 208 TABLE 175 GCC COUNTRIES: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 176 CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2024–2031 (USD MILLION) 210 TABLE 177 NORTH AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 210 TABLE 178 EUROPE: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 179 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 180 LATIN AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 181 MIDDLE EAST: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2024–2031 (USD MILLION) 212 TABLE 182 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 183 CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION, 2024–2031 (USD MILLION) 213 TABLE 184 NORTH AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 185 EUROPE: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 186 ASIA PACIFIC: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 187 LATIN AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 188 MIDDLE EAST: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION, 2024–2031 (USD MILLION) 215 TABLE 189 GCC COUNTRIES: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 190 CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2024–2031 (USD MILLION) 217 TABLE 191 NORTH AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 217 TABLE 192 EUROPE: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 193 ASIA PACIFIC: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 194 LATIN AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 195 MIDDLE EAST: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2024–2031 (USD MILLION) 219 TABLE 196 GCC COUNTRIES: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 197 CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2024–2031 (USD MILLION) 220 TABLE 198 NORTH AMERICA: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION) 221 TABLE 199 EUROPE: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION) 221 TABLE 200 ASIA PACIFIC: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 201 LATIN AMERICA: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 202 MIDDLE EAST: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2024–2031 (USD MILLION) 222 TABLE 203 GCC COUNTRIES: CELL CULTURE MARKET FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 204 CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY REGION, 2024–2031 (USD MILLION) 223 TABLE 205 NORTH AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 206 EUROPE: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 207 ASIA PACIFIC: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 225 TABLE 208 LATIN AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 225 TABLE 209 MIDDLE EAST: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY REGION, 2024–2031 (USD MILLION) 225 TABLE 210 GCC COUNTRIES: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 211 CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2024–2031 (USD MILLION) 227 TABLE 212 NORTH AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 213 EUROPE: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 214 ASIA PACIFIC: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 215 LATIN AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION) 229 TABLE 216 MIDDLE EAST: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2024–2031 (USD MILLION) 229 TABLE 217 GCC COUNTRIES: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2024–2031 (USD MILLION) 229 TABLE 218 CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2024–2031 (USD MILLION) 230 TABLE 219 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 220 EUROPE: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 231 TABLE 221 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 232 TABLE 222 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 232 TABLE 223 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2024–2031 (USD MILLION) 232 TABLE 224 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 225 CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 226 CELL CULTURE SERA MARKET, BY REGION, 2024–2031 (USD MILLION) 234 TABLE 227 NORTH AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 228 EUROPE: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 229 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 230 LATIN AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 231 MIDDLE EAST: CELL CULTURE SERA MARKET, BY REGION, 2024–2031 (USD MILLION) 236 TABLE 232 GCC COUNTRIES: CELL CULTURE SERA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 236 TABLE 233 CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2024–2031 (USD MILLION) 237 TABLE 234 NORTH AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 235 EUROPE: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 236 ASIA PACIFIC: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 237 LATIN AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION) 239 TABLE 238 MIDDLE EAST: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2024–2031 (USD MILLION) 239 TABLE 239 GCC COUNTRIES: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION) 239 TABLE 240 CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION, 2024–2031 (USD MILLION) 240 TABLE 241 NORTH AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 242 EUROPE: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 243 ASIA PACIFIC: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 244 LATIN AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 245 MIDDLE EAST: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION, 2024–2031 (USD MILLION) 242 TABLE 246 GCC COUNTRIES: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 247 CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2024–2031 (USD MILLION) 244 TABLE 248 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 249 EUROPE: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 250 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 251 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 252 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2024–2031 (USD MILLION) 246 TABLE 253 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 254 CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 247 TABLE 255 CELL CULTURE VESSELS MARKET, BY REGION, 2024–2031 (USD MILLION) 247 TABLE 256 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 257 EUROPE: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 258 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 259 LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 260 MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY REGION, 2024–2031 (USD MILLION) 249 TABLE 261 GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 250 TABLE 262 CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2024–2031 (USD MILLION) 251 TABLE 263 NORTH AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION) 251 TABLE 264 EUROPE: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 265 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 266 LATIN AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION) 253 TABLE 267 MIDDLE EAST: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2024–2031 (USD MILLION) 253 TABLE 268 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2024–2031 (USD MILLION) 253 TABLE 269 CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2024–2031 (USD MILLION) 254 TABLE 270 NORTH AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 271 EUROPE: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 272 ASIA PACIFIC: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 273 LATIN AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 274 MIDDLE EAST: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2024–2031 (USD MILLION) 256 TABLE 275 GCC COUNTRIES: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION) 257 TABLE 276 CELL CULTURE MARKET FOR FLASKS, BY REGION, 2024–2031 (USD MILLION) 258 TABLE 277 NORTH AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION) 258 TABLE 278 EUROPE: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION) 259 TABLE 279 ASIA PACIFIC: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION) 259 TABLE 280 LATIN AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 281 MIDDLE EAST: CELL CULTURE MARKET FOR FLASKS, BY REGION, 2024–2031 (USD MILLION) 260 TABLE 282 GCC COUNTRIES: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 283 CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2024–2031 (USD MILLION) 261 TABLE 284 NORTH AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 285 EUROPE: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 286 ASIA PACIFIC: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 287 LATIN AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 288 MIDDLE EAST: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2024–2031 (USD MILLION) 263 TABLE 289 GCC COUNTRIES: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 290 CELL CULTURE MARKET FOR PETRI DISHES, BY REGION, 2024–2031 (USD MILLION) 264 TABLE 291 NORTH AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION) 265 TABLE 292 EUROPE: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION) 265 TABLE 293 ASIA PACIFIC: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION) 266 TABLE 294 LATIN AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION) 266 TABLE 295 MIDDLE EAST: CELL CULTURE MARKET FOR PETRI DISHES, BY REGION, 2024–2031 (USD MILLION) 266 TABLE 296 GCC COUNTRIES: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2024–2031 (USD MILLION) 267 TABLE 297 CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY REGION, 2024–2031 (USD MILLION) 267 TABLE 298 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 299 EUROPE: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 300 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION) 269 TABLE 301 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION) 269 TABLE 302 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY REGION, 2024–2031 (USD MILLION) 269 TABLE 303 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER CONSUMABLES & ACCESSORIES, BY COUNTRY, 2024–2031 (USD MILLION) 270 TABLE 304 CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 305 CELL CULTURE EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 271 TABLE 306 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 307 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 272 TABLE 308 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 272 TABLE 309 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 273 TABLE 310 MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION) 273 TABLE 311 GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 273 TABLE 312 CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 313 CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY REGION, 2024–2031 (USD MILLION) 274 TABLE 314 NORTH AMERICA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 315 EUROPE: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 316 ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 276 TABLE 317 LATIN AMERICA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 276 TABLE 318 MIDDLE EAST: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY REGION, 2024–2031 (USD MILLION) 276 TABLE 319 GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 277 TABLE 320 FILTRATION SYSTEMS OFFERED BY KEY PLAYERS 278 TABLE 321 CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 278 TABLE 322 NORTH AMERICA: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 323 EUROPE: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 279 TABLE 324 ASIA PACIFIC: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 279 TABLE 325 LATIN AMERICA: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 280 TABLE 326 MIDDLE EAST: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 280 TABLE 327 GCC COUNTRIES: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 280 TABLE 328 CELL COUNTERS OFFERED BY KEY MARKET PLAYERS 281 TABLE 329 CELL CULTURE MARKET FOR CELL COUNTERS, BY REGION, 2024–2031 (USD MILLION) 282 TABLE 330 NORTH AMERICA: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2024–2031 (USD MILLION) 282 TABLE 331 EUROPE: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 332 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 333 LATIN AMERICA: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2024–2031 (USD MILLION) 284 TABLE 334 MIDDLE EAST: CELL CULTURE MARKET FOR CELL COUNTERS, BY REGION, 2024–2031 (USD MILLION) 284 TABLE 335 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2024–2031 (USD MILLION) 284 TABLE 336 CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS 285 TABLE 337 CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY REGION, 2024–2031 (USD MILLION) 286 TABLE 338 NORTH AMERICA: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2024–2031 (USD MILLION) 286 TABLE 339 EUROPE: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2024–2031 (USD MILLION) 287 TABLE 340 ASIA PACIFIC: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2024–2031 (USD MILLION) 287 TABLE 341 LATIN AMERICA: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2024–2031 (USD MILLION) 288 TABLE 342 MIDDLE EAST: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY REGION, 2024–2031 (USD MILLION) 288 TABLE 343 GCC COUNTRIES: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2024–2031 (USD MILLION) 288 TABLE 344 CENTRIFUGES OFFERED BY KEY MARKET PLAYERS 289 TABLE 345 CELL CULTURE MARKET FOR CENTRIFUGES, BY REGION, 2024–2031 (USD MILLION) 290 TABLE 346 NORTH AMERICA: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 347 EUROPE: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION) 291 TABLE 348 ASIA PACIFIC: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION) 291 TABLE 349 LATIN AMERICA: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION) 292 TABLE 350 MIDDLE EAST: CELL CULTURE MARKET FOR CENTRIFUGES, BY REGION, 2024–2031 (USD MILLION) 292 TABLE 351 GCC COUNTRIES: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2024–2031 (USD MILLION) 292 TABLE 352 CELL CULTURE MARKET FOR AUTOCLAVES, BY REGION, 2024–2031 (USD MILLION) 293 TABLE 353 NORTH AMERICA: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2024–2031 (USD MILLION) 294 TABLE 354 EUROPE: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2024–2031 (USD MILLION) 294 TABLE 355 ASIA PACIFIC: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2024–2031 (USD MILLION) 295 TABLE 356 LATIN AMERICA: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2024–2031 (USD MILLION) 295 TABLE 357 MIDDLE EAST: CELL CULTURE MARKET FOR AUTOCLAVES, BY REGION, 2024–2031 (USD MILLION) 295 TABLE 358 GCC COUNTRIES: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 359 CELL CULTURE MARKET FOR MICROSCOPES, BY REGION, 2024–2031 (USD MILLION) 297 TABLE 360 NORTH AMERICA: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2024–2031 (USD MILLION) 297 TABLE 361 EUROPE: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2024–2031 (USD MILLION) 298 TABLE 362 ASIA PACIFIC: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2024–2031 (USD MILLION) 298 TABLE 363 LATIN AMERICA: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2024–2031 (USD MILLION) 299 TABLE 364 MIDDLE EAST: CELL CULTURE MARKET FOR MICROSCOPES, BY REGION, 2024–2031 (USD MILLION) 299 TABLE 365 GCC COUNTRIES: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2024–2031 (USD MILLION) 299 TABLE 366 BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS 300 TABLE 367 CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY REGION, 2024–2031 (USD MILLION) 301 TABLE 368 NORTH AMERICA: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2024–2031 (USD MILLION) 301 TABLE 369 EUROPE: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2024–2031 (USD MILLION) 302 TABLE 370 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2024–2031 (USD MILLION) 302 TABLE 371 LATIN AMERICA: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2024–2031 (USD MILLION) 303 TABLE 372 MIDDLE EAST: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY REGION, 2024–2031 (USD MILLION) 303 TABLE 373 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2024–2031 (USD MILLION) 303 TABLE 374 OTHER SUPPORTING EQUIPMENT OFFERED BY KEY MARKET PLAYERS 304 TABLE 375 CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY REGION, 2024–2031 (USD MILLION) 304 TABLE 376 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 377 EUROPE: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 378 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 306 TABLE 379 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 306 TABLE 380 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY REGION, 2024–2031 (USD MILLION) 306 TABLE 381 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 307 TABLE 382 COMMERCIALLY AVAILABLE BIOREACTORS BY KEY PLAYERS 308 TABLE 383 CELL CULTURE MARKET FOR BIOREACTORS, BY REGION, 2024–2031 (USD MILLION) 308 TABLE 384 NORTH AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 309 TABLE 385 EUROPE: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 309 TABLE 386 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 310 TABLE 387 LATIN AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 310 TABLE 388 MIDDLE EAST: CELL CULTURE MARKET FOR BIOREACTORS, BY REGION, 2024–2031 (USD MILLION) 310 TABLE 389 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2024–2031 (USD MILLION) 311 TABLE 390 CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 311 TABLE 391 CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY REGION, 2024–2031 (USD MILLION) 312 TABLE 392 NORTH AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 312 TABLE 393 EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 313 TABLE 394 ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 313 TABLE 395 LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 314 TABLE 396 MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY REGION, 2024–2031 (USD MILLION) 314 TABLE 397 GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 314 TABLE 398 CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY REGION, 2024–2031 (USD MILLION) 315 TABLE 399 NORTH AMERICA: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2024–2031 (USD MILLION) 316 TABLE 400 EUROPE: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2024–2031 (USD MILLION) 316 TABLE 401 ASIA PACIFIC: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 402 LATIN AMERICA: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 403 MIDDLE EAST: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY REGION, 2024–2031 (USD MILLION) 317 TABLE 404 GCC COUNTRIES: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2024–2031 (USD MILLION) 318 TABLE 405 CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 319 TABLE 406 NORTH AMERICA: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 319 TABLE 407 EUROPE: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 320 TABLE 408 ASIA PACIFIC: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 320 TABLE 409 LATIN AMERICA: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 321 TABLE 410 MIDDLE EAST: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 321 TABLE 411 GCC COUNTRIES: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 321 TABLE 412 CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 323 TABLE 413 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 414 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2024–2031 (USD MILLION) 324 TABLE 415 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 325 TABLE 416 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 325 TABLE 417 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 326 TABLE 418 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 326 TABLE 419 MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2024–2031 (USD MILLION) 326 TABLE 420 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 327 TABLE 421 CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2024–2031 (USD MILLION) 328 TABLE 422 NORTH AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 328 TABLE 423 EUROPE: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 329 TABLE 424 ASIA PACIFIC: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 329 TABLE 425 LATIN AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 330 TABLE 426 MIDDLE EAST: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2024–2031 (USD MILLION) 330 TABLE 427 GCC COUNTRIES: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 330 TABLE 428 CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2024–2031 (USD MILLION) 332 TABLE 429 NORTH AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 332 TABLE 430 EUROPE: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 333 TABLE 431 ASIA PACIFIC: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 333 TABLE 432 LATIN AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 433 MIDDLE EAST: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2024–2031 (USD MILLION) 334 TABLE 434 GCC COUNTRIES: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 435 CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2024–2031 (USD MILLION) 335 TABLE 436 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 336 TABLE 437 EUROPE: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 336 TABLE 438 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 337 TABLE 439 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 337 TABLE 440 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2024–2031 (USD MILLION) 337 TABLE 441 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2024–2031 (USD MILLION) 338 TABLE 442 CELL CULTURE MARKET FOR DIAGNOSTICS APPLICATION, BY REGION, 2024–2031 (USD MILLION) 339 TABLE 443 NORTH AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 339 TABLE 444 EUROPE: CELL CULTURE MARKET FOR DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 340 TABLE 445 ASIA PACIFIC: CELL CULTURE MARKET FOR DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 340 TABLE 446 LATIN AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 341 TABLE 447 MIDDLE EAST: CELL CULTURE MARKET FOR DIAGNOSTICS APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 341 TABLE 448 GCC COUNTRIES: CELL CULTURE MARKET FOR DIAGNOSTICS APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 341 TABLE 449 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 450 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2024–2031 (USD MILLION) 343 TABLE 451 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION) 344 TABLE 452 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION) 344 TABLE 453 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION) 345 TABLE 454 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION) 345 TABLE 455 MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2024–2031 (USD MILLION) 345 TABLE 456 GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2024–2031 (USD MILLION) 346 TABLE 457 CELL CULTURE MARKET FOR CELL & GENE THERAPY APPLICATION, BY REGION, 2024–2031 (USD MILLION) 347 TABLE 458 NORTH AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 348 TABLE 459 EUROPE: CELL CULTURE MARKET FOR CELL & GENE THERAPY APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 348 TABLE 460 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL & GENE THERAPY APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 349 TABLE 461 LATIN AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 349 TABLE 462 MIDDLE EAST: CELL CULTURE MARKET FOR CELL & GENE THERAPY APPLICATION, BY REGION, 2024–2031 (USD MILLION) 349 TABLE 463 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL & GENE THERAPY APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 350 TABLE 464 CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 350 TABLE 465 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 351 TABLE 466 EUROPE: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 351 TABLE 467 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 352 TABLE 468 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 352 TABLE 469 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 352 TABLE 470 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 353 TABLE 471 CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 354 TABLE 472 NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 354 TABLE 473 EUROPE: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 355 TABLE 474 ASIA PACIFIC: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 355 TABLE 475 LATIN AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 356 TABLE 476 MIDDLE EAST: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 356 TABLE 477 GCC COUNTRIES: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 356 TABLE 478 CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 357 TABLE 479 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 357 TABLE 480 EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 358 TABLE 481 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 358 TABLE 482 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 359 TABLE 483 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 359 TABLE 484 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 359 TABLE 485 CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 361 TABLE 486 CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 362 TABLE 487 NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 363 TABLE 488 EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 363 TABLE 489 ASIA PACIFIC: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 364 TABLE 490 LATIN AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 364 TABLE 491 MIDDLE EAST: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 364 TABLE 492 GCC COUNTRIES: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 365 TABLE 493 CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 366 TABLE 494 NORTH AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 366 TABLE 495 EUROPE: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 367 TABLE 496 ASIA PACIFIC: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 367 TABLE 497 LATIN AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 368 TABLE 498 MIDDLE EAST: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 368 TABLE 499 GCC COUNTRIES: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 368 TABLE 500 CELL CULTURE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 369 TABLE 501 NORTH AMERICA: CELL CULTURE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 370 TABLE 502 EUROPE: CELL CULTURE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 370 TABLE 503 ASIA PACIFIC: CELL CULTURE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 371 TABLE 504 LATIN AMERICA: CELL CULTURE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 371 TABLE 505 MIDDLE EAST: CELL CULTURE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 371 TABLE 506 GCC COUNTRIES: CELL CULTURE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 372 TABLE 507 CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 373 TABLE 508 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 373 TABLE 509 EUROPE: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 374 TABLE 510 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 374 TABLE 511 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 375 TABLE 512 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 375 TABLE 513 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 375 TABLE 514 CELL CULTURE MARKET, BY REGION, 2024–2031 (USD MILLION) 377 TABLE 515 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 378 TABLE 516 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 379 TABLE 517 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 518 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 519 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 520 NORTH AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 521 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 522 NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 523 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 382 TABLE 524 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 382 TABLE 525 NORTH AMERICA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 383 TABLE 526 NORTH AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 383 TABLE 527 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 384 TABLE 528 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 384 TABLE 529 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 530 NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 385 TABLE 531 INDICATIVE LIST OF CELL AND GENE THERAPIES APPROVED IN 2025-2026 386 TABLE 532 US: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 386 TABLE 533 US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 534 US: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 535 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 536 US: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 537 US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 538 US: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 539 US: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 540 US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 541 US: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 542 US: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 543 US: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 391 TABLE 544 US: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 545 US: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 392 TABLE 546 US: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 392 TABLE 547 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 393 TABLE 548 CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 549 CANADA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 550 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 551 CANADA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 552 CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 553 CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 396 TABLE 554 CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 396 TABLE 555 CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 396 TABLE 556 CANADA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 557 CANADA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 558 CANADA: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 398 TABLE 559 CANADA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 398 TABLE 560 CANADA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 398 TABLE 561 CANADA: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 399 TABLE 562 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 399 TABLE 563 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 400 TABLE 564 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 565 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 566 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 567 EUROPE: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 568 EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 402 TABLE 569 EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 402 TABLE 570 EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 571 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 572 EUROPE: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 573 EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 574 EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 405 TABLE 575 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 405 TABLE 576 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY EEEE, 2024–2031 (USD MILLION) 405 TABLE 577 EUROPE: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 406 TABLE 578 GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 406 TABLE 579 GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 580 GERMANY: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 581 GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 582 GERMANY: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 583 GERMANY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 584 GERMANY: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 585 GERMANY: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 586 GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 587 GERMANY: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 588 GERMANY: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 589 GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 411 TABLE 590 GERMANY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 411 TABLE 591 GERMANY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 411 TABLE 592 GERMANY: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 412 TABLE 593 UK: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 412 TABLE 594 UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 413 TABLE 595 UK: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 413 TABLE 596 UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 413 TABLE 597 UK: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 414 TABLE 598 UK: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 414 TABLE 599 UK: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 600 UK: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 601 UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 602 UK: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 603 UK: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 604 UK: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 417 TABLE 605 UK: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 606 UK: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 607 UK: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 418 TABLE 608 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 418 TABLE 609 FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 610 FRANCE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 611 FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 612 FRANCE: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 420 TABLE 613 FRANCE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 420 TABLE 614 FRANCE: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 421 TABLE 615 FRANCE: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 421 TABLE 616 FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 421 TABLE 617 FRANCE: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 618 FRANCE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 619 FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 423 TABLE 620 FRANCE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 621 FRANCE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY EEEE, 2024–2031 (USD MILLION) 423 TABLE 622 FRANCE: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 424 TABLE 623 ITALY: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 424 TABLE 624 ITALY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 625 ITALY: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 626 ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 627 ITALY: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 628 ITALY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 629 ITALY: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 427 TABLE 630 ITALY: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 427 TABLE 631 ITALY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 427 TABLE 632 ITALY: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 428 TABLE 633 ITALY: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 428 TABLE 634 ITALY: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 429 TABLE 635 ITALY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 636 ITALY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 637 ITALY: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 430 TABLE 638 SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 430 TABLE 639 SPAIN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 640 SPAIN: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 641 SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 642 SPAIN: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 643 SPAIN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 644 SPAIN: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 645 SPAIN: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 646 SPAIN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 647 SPAIN: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 434 TABLE 648 SPAIN: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 434 TABLE 649 SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 435 TABLE 650 SPAIN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 435 TABLE 651 SPAIN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 435 TABLE 652 SPAIN: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 436 TABLE 653 REST OF EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 436 TABLE 654 REST OF EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 655 REST OF EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE 2024–2031 (USD MILLION) 437 TABLE 656 REST OF EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 657 REST OF EUROPE: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 658 REST OF EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 659 REST OF EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 660 REST OF EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 661 REST OF EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 662 REST OF EUROPE: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 440 TABLE 663 REST OF EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 440 TABLE 664 REST OF EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 441 TABLE 665 REST OF EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 441 TABLE 666 REST OF EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 441 TABLE 667 REST OF EUROPE: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 442 TABLE 668 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 443 TABLE 669 ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 444 TABLE 670 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 671 ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 444 TABLE 672 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 673 ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 674 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 675 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 676 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 677 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 678 ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 679 ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 680 ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 449 TABLE 681 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 682 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 450 TABLE 683 ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 450 TABLE 684 CHINA: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 451 TABLE 685 CHINA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 451 TABLE 686 CHINA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 451 TABLE 687 CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 688 CHINA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 689 CHINA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 690 CHINA: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 691 CHINA: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 692 CHINA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 693 CHINA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 694 CHINA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 695 CHINA: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 456 TABLE 696 CHINA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 697 CHINA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 698 CHINA: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 457 TABLE 699 JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 457 TABLE 700 JAPAN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 701 JAPAN: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 702 JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 703 JAPAN: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 704 JAPAN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 705 JAPAN: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 706 JAPAN: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 707 JAPAN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 708 JAPAN: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 461 TABLE 709 JAPAN: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 461 TABLE 710 JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 462 TABLE 711 JAPAN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 712 JAPAN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 713 JAPAN: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 463 TABLE 714 INDIA: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 463 TABLE 715 INDIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 464 TABLE 716 INDIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 464 TABLE 717 INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 464 TABLE 718 INDIA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 719 INDIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 720 INDIA: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 721 INDIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 722 INDIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 723 INDIA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 724 INDIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 725 INDIA: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 468 TABLE 726 INDIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 468 TABLE 727 INDIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 468 TABLE 728 INDIA: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 469 TABLE 729 SOUTH KOREA: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 469 TABLE 730 SOUTH KOREA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 470 TABLE 731 SOUTH KOREA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 470 TABLE 732 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 470 TABLE 733 SOUTH KOREA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 471 TABLE 734 SOUTH KOREA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 471 TABLE 735 SOUTH KOREA: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 736 SOUTH KOREA: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 737 SOUTH KOREA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 738 SOUTH KOREA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 739 SOUTH KOREA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 740 SOUTH KOREA: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 474 TABLE 741 SOUTH KOREA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 742 SOUTH KOREA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 743 SOUTH KOREA: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 475 TABLE 744 AUSTRALIA: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 475 TABLE 745 AUSTRALIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 746 AUSTRALIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 747 AUSTRALIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 748 AUSTRALIA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 749 AUSTRALIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 750 AUSTRALIA: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 478 TABLE 751 AUSTRALIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 478 TABLE 752 AUSTRALIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 478 TABLE 753 AUSTRALIA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 479 TABLE 754 AUSTRALIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 479 TABLE 755 AUSTRALIA: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 480 TABLE 756 AUSTRALIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 757 AUSTRALIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 758 AUSTRALIA: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 481 TABLE 759 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 481 TABLE 760 REST OF ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 761 REST OF ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 762 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 763 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 764 REST OF ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 765 REST OF ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 766 REST OF ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 485 TABLE 767 REST OF ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 485 TABLE 768 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 486 TABLE 769 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 486 TABLE 770 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 487 TABLE 771 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 772 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 773 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 488 TABLE 774 LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 488 TABLE 775 LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 489 TABLE 776 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 777 LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 778 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 779 LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 780 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 491 TABLE 781 LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 491 TABLE 782 LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 492 TABLE 783 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 492 TABLE 784 LATIN AMERICA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 493 TABLE 785 LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 493 TABLE 786 LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 494 TABLE 787 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 788 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 789 LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 495 TABLE 790 BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 495 TABLE 791 BRAZIL: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 792 BRAZIL: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 793 BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 794 BRAZIL: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 795 BRAZIL: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 796 BRAZIL: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 797 BRAZIL: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 798 BRAZIL: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 799 BRAZIL: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 499 TABLE 800 BRAZIL: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 499 TABLE 801 BRAZIL: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 500 TABLE 802 BRAZIL: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 500 TABLE 803 BRAZIL: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 500 TABLE 804 BRAZIL: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 501 TABLE 805 MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 501 TABLE 806 MEXICO: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 807 MEXICO: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 808 MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 809 MEXICO: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 810 MEXICO: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 811 MEXICO: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 504 TABLE 812 MEXICO: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 504 TABLE 813 MEXICO: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 504 TABLE 814 MEXICO: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 815 MEXICO: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 816 MEXICO: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 506 TABLE 817 MEXICO: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 818 MEXICO: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 819 MEXICO: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 507 TABLE 820 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 507 TABLE 821 REST OF LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 822 REST OF LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 823 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 824 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 825 REST OF LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 826 REST OF LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 827 REST OF LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 828 REST OF LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 829 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 512 TABLE 830 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 512 TABLE 831 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 513 TABLE 832 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 833 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 514 TABLE 834 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 514 TABLE 835 MIDDLE EAST: CELL CULTURE MARKET, BY REGION, 2024–2031 (USD MILLION) 515 TABLE 836 MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 515 TABLE 837 MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 515 TABLE 838 MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 839 MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 840 MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 841 MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 842 MIDDLE EAST: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 518 TABLE 843 MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 518 TABLE 844 MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 518 TABLE 845 MIDDLE EAST: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 519 TABLE 846 MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 519 TABLE 847 MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 520 TABLE 848 MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 520 TABLE 849 MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 520 TABLE 850 MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 521 TABLE 851 GCC COUNTRIES: CELL CULTURE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 521 TABLE 852 GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 522 TABLE 853 GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 522 TABLE 854 GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 522 TABLE 855 GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 856 GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 857 GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 858 GCC COUNTRIES: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 859 GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 860 GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 861 GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 862 GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 526 TABLE 863 GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 526 TABLE 864 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 526 TABLE 865 GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 527 TABLE 866 GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 527 TABLE 867 SAUDI ARABIA: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 528 TABLE 868 SAUDI ARABIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 528 TABLE 869 SAUDI ARABIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 528 TABLE 870 SAUDI ARABIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 529 TABLE 871 SAUDI ARABIA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 529 TABLE 872 SAUDI ARABIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 873 SAUDI ARABIA: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 874 SAUDI ARABIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 875 SAUDI ARABIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 876 SAUDI ARABIA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 877 SAUDI ARABIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 878 SAUDI ARABIA: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 532 TABLE 879 SAUDI ARABIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 880 SAUDI ARABIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 881 SAUDI ARABIA: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 533 TABLE 882 UAE: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 533 TABLE 883 UAE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 534 TABLE 884 UAE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 534 TABLE 885 UAE: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 534 TABLE 886 UAE: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 535 TABLE 887 UAE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 535 TABLE 888 UAE: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 536 TABLE 889 UAE: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 536 TABLE 890 UAE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 536 TABLE 891 UAE: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 537 TABLE 892 UAE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 537 TABLE 893 UAE: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 538 TABLE 894 UAE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 895 UAE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 896 UAE: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 539 TABLE 897 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 539 TABLE 898 REST OF GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 540 TABLE 899 REST OF GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 540 TABLE 900 REST OF GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 540 TABLE 901 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 902 REST OF GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 903 REST OF GCC COUNTRIES: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 904 REST OF GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 905 REST OF GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 906 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 543 TABLE 907 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 543 TABLE 908 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 544 TABLE 909 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 544 TABLE 910 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 544 TABLE 911 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 545 TABLE 912 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 545 TABLE 913 REST OF MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 914 REST OF MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 915 REST OF MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 916 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 547 TABLE 917 REST OF MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 547 TABLE 918 REST OF MIDDLE EAST: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 548 TABLE 919 REST OF MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 548 TABLE 920 REST OF MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 548 TABLE 921 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 922 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 923 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION 2024–2031 (USD MILLION) 550 TABLE 924 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 550 TABLE 925 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 550 TABLE 926 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 551 TABLE 927 AFRICA: CELL CULTURE MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 551 TABLE 928 AFRICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 552 TABLE 929 AFRICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 552 TABLE 930 AFRICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2024–2031 (USD MILLION) 552 TABLE 931 AFRICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 932 AFRICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 933 AFRICA: CELL CULTURE SERA MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 934 AFRICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 935 AFRICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 936 AFRICA: CELL CULTURE MARKET FOR SUPPORTING EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 555 TABLE 937 AFRICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION) 555 TABLE 938 AFRICA: CELL CULTURE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 556 TABLE 939 AFRICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2024–2031 (USD MILLION) 556 TABLE 940 AFRICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2024–2031 (USD MILLION) 556 TABLE 941 AFRICA: CELL CULTURE MARKET, BY END USER, 2024–2031 (USD MILLION) 557 TABLE 942 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, JANUARY 2023–MAY 2026 558 TABLE 943 CELL CULTURE MARKET: DEGREE OF COMPETITION 562 TABLE 944 CELL CULTURE MARKET: REGIONAL FOOTPRINT, 2025 566 TABLE 945 CELL CULTURE MARKET: PRODUCT FOOTPRINT, 2025 567 TABLE 946 CELL CULTURE MARKET: APPLICATION FOOTPRINT, 2025 568 TABLE 947 CELL CULTURE MARKET: END-USER FOOTPRINT, 2025 569 TABLE 948 CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025 571 TABLE 949 CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT AND REGION ,2025 572 TABLE 950 CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 575 TABLE 951 CELL CULTURE MARKET: DEALS, JANUARY 2023–MAY 2026 575 TABLE 952 CELL CULTURE MARKET: EXPANSIONS, JANUARY 2023–MAY 2026 576 TABLE 953 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 578 TABLE 954 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 579 TABLE 955 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES 592 TABLE 956 THERMO FISHER SCIENTIFIC INC.: DEALS 594 TABLE 957 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS 595 TABLE 958 DANAHER CORPORATION: COMPANY OVERVIEW 597 TABLE 959 DANAHER CORPORATION: PRODUCTS OFFERED 598 TABLE 960 DANAHER CORPORATION: PRODUCT LAUNCHES 608 TABLE 961 DANAHER CORPORATION: DEALS 609 TABLE 962 DANAHER CORPORATION: EXPANSIONS 610 TABLE 963 DANAHER CORPORATION: OTHER DEVELOPMENTS 611 TABLE 964 MERCK KGAA: COMPANY OVERVIEW 613 TABLE 965 MERCK KGAA: PRODUCTS OFFERED 614 TABLE 966 MERCK KGAA: PRODUCT LAUNCHES 621 TABLE 967 MERCK KGAA: DEALS 621 TABLE 968 MERCK KGAA: EXPANSIONS 622 TABLE 969 SARTORIUS AG: COMPANY OVERVIEW 625 TABLE 970 SARTORIUS AG: PRODUCTS OFFERED 626 TABLE 971 SARTORIUS AG: PRODUCT LAUNCHES 634 TABLE 972 SARTORIUS AG.: DEALS 635 TABLE 973 SARTORIUS AG: EXPANSIONS, JANUARY 2023–MAY 2026 637 TABLE 974 CORNING INCORPORATED: COMPANY OVERVIEW 640 TABLE 975 CORNING INCORPORATED: PRODUCTS OFFERED 641 TABLE 976 CORNING INCORPORATED: DEALS 650 TABLE 977 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 652 TABLE 978 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED 653 TABLE 979 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES 659 TABLE 980 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023–MAY 2026 660 TABLE 981 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS 660 TABLE 982 BD: COMPANY OVERVIEW 661 TABLE 983 BD: PRODUCTS OFFERED 662 TABLE 984 BD: PRODUCT LAUNCHES 664 TABLE 985 BD: DEALS, JANUARY 2023–MAY 2026 664 TABLE 986 BD: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 665 TABLE 987 EPPENDORF SE: COMPANY OVERVIEW 666 TABLE 988 EPPENDORF SE: PRODUCTS OFFERED 667 TABLE 989 EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 672 TABLE 990 EPPENDORF SE: EXPANSIONS 673 TABLE 991 LONZA: COMPANY OVERVIEW 674 TABLE 992 LONZA: PRODUCTS OFFERED 675 TABLE 993 LONZA: PRODUCT LAUNCHES 678 TABLE 994 LONZA: DEALS, JANUARY 2023–MAY 2026 678 TABLE 995 GETINGE: COMPANY OVERVIEW 679 TABLE 996 GETINGE: PRODUCTS OFFERED 680 TABLE 997 GETINGE: PRODUCT LAUNCHES 681 TABLE 998 GETINGE: DEALS, JANUARY 2023–MAY 2026 682 TABLE 999 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 683 TABLE 1000 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 684 TABLE 1001 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES 686 TABLE 1002 AGILENT TECHNOLOGIES, INC.: DEALS 687 TABLE 1003 AGILENT TECHNOLOGIES, INC.: EXPANSIONS 687 TABLE 1004 HIMEDIA LABORATORIES: COMPANY OVERVIEW 688 TABLE 1005 HIMEDIA LABORATORIES: PRODUCTS OFFERED 688 TABLE 1006 BIO-TECHNE: COMPANY OVERVIEW 692 TABLE 1007 BIO-TECHNE: PRODUCTS OFFERED 693 TABLE 1008 BIO-TECHNE: PRODUCT LAUNCHES 697 TABLE 1009 BIO-TECHNE: DEALS 697 TABLE 1010 BIO-TECHNE: EXPANSIONS 698 TABLE 1011 MILTENYI BIOTEC: COMPANY OVERVIEW 699 TABLE 1012 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW 701 TABLE 1013 SOLIDA BIOTECH GMBH: COMPANY OVERVIEW 704 TABLE 1014 CAISSON LABS: COMPANY OVERVIEW 705 TABLE 1015 PROMOCELL GMBH: COMPANY OVERVIEW 706 TABLE 1016 INVIVOGEN: COMPANY OVERVIEW 707 TABLE 1017 PAN-BIOTECH: COMPANY OVERVIEW 708 TABLE 1018 CELLEXUS: COMPANY OVERVIEW 709 TABLE 1019 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW 710 TABLE 1020 ADOLF KÜHNER AG: COMPANY OVERVIEW 712 TABLE 1021 ADVANCION CORPORATION: COMPANY OVERVIEW 713 TABLE 1022 BIOSPHERIX LLC: COMPANY OVERVIEW 714 TABLE 1023 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 723 TABLE 1024 RISK ASSESSMENT 726 FIGURE 1 CELL CULTURE MARKET SEGMENTATION 62 FIGURE 2 CELL CULTURE MARKET REGIONS COVERED 63 FIGURE 3 CELL CULTURE MARKET: YEARS CONSIDERED 63 FIGURE 4 MARKET SCENARIO 67 FIGURE 5 GLOBAL CELL CULTURE MARKET, 2024–2031 67 FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, 2023–2026 68 FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF CELL CULTURE MARKET 69 FIGURE 8 HIGH-GROWTH SEGMENTS IN CELL CULTURE MARKET, 2026–2031 70 FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN CELL CULTURE MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 71 FIGURE 10 INCREASING ADOPTION OF SINGLE-USE TECHNOLOGIES TO DRIVE MARKET GROWTH 72 FIGURE 11 US AND SERA, MEDIA, REAGENTS ACCOUNTED FOR LARGEST SHARE OF CELL CULTURE MARKET IN NORTH AMERICA IN 2025 73 FIGURE 12 ASIA PACIFIC LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL CELL CULTURE MARKET DURING FORECAST PERIOD 74 FIGURE 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 74 FIGURE 14 CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 75 FIGURE 15 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU, 2012−2025 81 FIGURE 16 NUMBER OF BIOSIMILARS APPROVED AND LAUNCHED, 2015−2025 81 FIGURE 17 CLINICAL TRIAL OVERVIEW OF TISSUE-ENGINEERED PRODUCTS, 2019–2025 83 FIGURE 18 CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS 92 FIGURE 19 GLOBAL GDP GROWTH, 2020–2030 94 FIGURE 20 CELL CULTURE MARKET: VALUE CHAIN ANALYSIS 95 FIGURE 21 CELL CULTURE MARKET ECOSYSTEM 97 FIGURE 22 AVERAGE SELLING PRICE TREND OF CELL CULTURE PRODUCTS, 2023–2025 (USD) 101 FIGURE 23 AVERAGE SELLING PRICE OF CELL CULTURE PRODUCTS, BY REGION, 2025 (USD) 102 FIGURE 24 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN CELL CULTURE MARKET 107 FIGURE 25 CELL CULTURE MARKET: STARTUP FUNDING FOR GENE, CELL, AND RNA THERAPY COMPANIES, 2025–2026 (USD MILLION) 107 FIGURE 26 CELL CULTURE MARKET: INVESTMENTS BY DEAL TYPE FOR ALL REGIONS, Q4 2025 109 FIGURE 27 TOP APPLICANTS/OWNERS (COMPANIES) FOR CELL CULTURE PATENTS, 2015–2025 119 FIGURE 28 IMPACT OF AI/GEN AI ON CELL CULTURE MARKET 123 FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL CULTURE PRODUCTS 134 FIGURE 30 KEY BUYING CRITERIA, BY END USER 135 FIGURE 31 ONGOING CLINICAL TRIALS BY PHASE AND THERAPEUTIC APPROACH 347 FIGURE 32 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT 378 FIGURE 33 ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT 443 FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2021–2025 (USD BILLION) 561 FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2025 562 FIGURE 36 CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 565 FIGURE 37 CELL CULTURE MARKET: COMPANY FOOTPRINT, 2025 566 FIGURE 38 CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 571 FIGURE 39 EV/EBITDA OF KEY VENDORS, 2026 573 FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2026 573 FIGURE 41 CELL CULTURE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 574 FIGURE 42 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 579 FIGURE 43 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 598 FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2025) 614 FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2025) 626 FIGURE 46 CORNING INCORPORATED: COMPANY SNAPSHOT (2025) 641 FIGURE 47 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025) 653 FIGURE 48 BD: COMPANY SNAPSHOT (2025) 662 FIGURE 49 EPPENDORF SE: COMPANY SNAPSHOT (2024) 667 FIGURE 50 LONZA: COMPANY SNAPSHOT (2025) 675 FIGURE 51 GETINGE: COMPANY SNAPSHOT (2025) 680 FIGURE 52 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 684 FIGURE 53 BIO-TECHNE: COMPANY SNAPSHOT (2025) 693 FIGURE 54 CELL CULTURE MARKET: RESEARCH DESIGN 715 FIGURE 55 CELL CULTURE MARKET: BREAKDOWN OF PRIMARIES 717 FIGURE 56 GLOBAL CELL CULTURE MARKET ESTIMATION, 2025 718 FIGURE 57 CELL CULTURE MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025) 719 FIGURE 58 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE ANALYSIS (2025) 719 FIGURE 59 CELL CULTURE MARKET: INSIGHTS FROM PRIMARIES 720 FIGURE 60 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 721 FIGURE 61 CELL CULTURE MARKET: CAGR PROJECTIONS 722 FIGURE 62 CELL CULTURE MARKET: DATA TRIANGULATION 724